Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Overview

This article presents a protocol for renal sympathetic denervation (RDN) in mice with hypertension induced by Angiotensin II infusion. The procedure is designed to be repeatable and convenient, allowing researchers to study the regulatory mechanisms of RDN on hypertension and cardiac hypertrophy.

Key Study Components

Area of Science

• Neuroscience
• Cardiology
• Hypertension Research

Background

• Renal sympathetic denervation is a potential treatment for hypertension.
• This technique denervates renal nerves without damaging the renal artery.
• It has been validated through numerous clinical trials.
• The model is simple, critical, repeatable, and standardized.

Purpose of Study

• To demonstrate the RDN procedure in a mouse model.
• To explore the effects of RDN on hypertension and cardiac hypertrophy.
• To provide a reliable method for future research in this area.

Methods Used

• Disinfection of the operation table with 70% ethanol.
• Adjustment of the heating pad to 37 degrees Celsius.
• Sterilization of surgical instruments at 121 degrees Celsius for 30 minutes.
• Demonstration of the procedure by a lab assistant.

Main Results

• The RDN procedure is effective in denervating renal nerves.
• No damage to the renal artery was observed.
• The model allows for repeatable studies on hypertension.
• Potential implications for future hypertension treatments.

Conclusions

• RDN is a promising approach for studying hypertension.
• The protocol is accessible for researchers in the field.
• Further studies could enhance understanding of RDN's effects.

Frequently Asked Questions